BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23578479)

  • 1. New vaccines for neglected parasitic diseases and dengue.
    Beaumier CM; Gillespie PM; Hotez PJ; Bottazzi ME
    Transl Res; 2013 Sep; 162(3):144-55. PubMed ID: 23578479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
    Seid CA; Curti E; Jones RM; Hudspeth E; Rezende W; Pollet J; Center L; Versteeg L; Pritchard S; Musiychuk K; Yusibov V; Hotez PJ; Bottazzi ME
    Hum Vaccin Immunother; 2015; 11(6):1474-88. PubMed ID: 25905574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases.
    Hotez P
    Vaccine; 2011 Dec; 29 Suppl 4():D104-10. PubMed ID: 22188933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Vaccines for the World's Poorest People.
    Hotez PJ; Bottazzi ME; Strych U
    Annu Rev Med; 2016; 67():405-17. PubMed ID: 26356803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas.
    Hotez PJ; Dumonteil E; Heffernan MJ; Bottazzi ME
    Adv Exp Med Biol; 2013; 764():1-12. PubMed ID: 23654053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neglected tropical disease vaccines.
    Hotez PJ; Brown AS
    Biologicals; 2009 Jun; 37(3):160-4. PubMed ID: 19278869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines to combat the neglected tropical diseases.
    Bethony JM; Cole RN; Guo X; Kamhawi S; Lightowlers MW; Loukas A; Petri W; Reed S; Valenzuela JG; Hotez PJ
    Immunol Rev; 2011 Jan; 239(1):237-70. PubMed ID: 21198676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
    Keitel WA; Potter GE; Diemert D; Bethony J; El Sahly HM; Kennedy JK; Patel SM; Plieskatt JL; Jones W; Deye G; Bottazzi ME; Hotez PJ; Atmar RL
    Vaccine; 2019 Oct; 37(43):6500-6509. PubMed ID: 31515141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases.
    Bottazzi ME; Miles AP; Diemert D; Hotez PJ
    Expert Rev Vaccines; 2006 Apr; 5(2):189-98. PubMed ID: 16608419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
    Bottazzi ME; Brown AS
    Expert Rev Vaccines; 2008 Dec; 7(10):1481-92. PubMed ID: 19053205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults.
    Diemert DJ; Zumer M; Campbell D; Grahek S; Li G; Peng J; Elena Bottazzi M; Hotez P; Bethony J
    Vaccine; 2022 Oct; 40(42):6084-6092. PubMed ID: 36114129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing a vaccine to prevent hookworm disease and anemia.
    Hotez PJ; Beaumier CM; Gillespie PM; Strych U; Hayward T; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):3001-3005. PubMed ID: 27040400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consultation on dengue vaccines: progress in understanding protection, 26-28 June 2013, Rockville, Maryland.
    Cassetti MC; Halstead SB
    Vaccine; 2014 May; 32(26):3115-21. PubMed ID: 24768502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of dengue virus and the development of a vaccine.
    Murrell S; Wu SC; Butler M
    Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of vaccine research and development of vaccines for leishmaniasis.
    Gillespie PM; Beaumier CM; Strych U; Hayward T; Hotez PJ; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):2992-2995. PubMed ID: 26973063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for the prevention of neglected diseases--dengue fever.
    Pang T
    Curr Opin Biotechnol; 2003 Jun; 14(3):332-6. PubMed ID: 12849789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency testing for the experimental Na-GST-1 hookworm vaccine.
    Jariwala AR; Oliveira LM; Diemert DJ; Keegan B; Plieskatt JL; Periago MV; Bottazzi ME; Hotez PJ; Bethony JM
    Expert Rev Vaccines; 2010 Oct; 9(10):1219-30. PubMed ID: 20923271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.